These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1468 related items for PubMed ID: 12688351

  • 1. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [Abstract] [Full Text] [Related]

  • 2. Mastocytosis: state of the art.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2007 Feb; 74(2):121-32. PubMed ID: 17587883
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM.
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [Abstract] [Full Text] [Related]

  • 4. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
    Noack F, Sotlar K, Notter M, Thiel E, Valent P, Horny HP.
    Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
    [Abstract] [Full Text] [Related]

  • 5. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
    Jordan JH, Fritsche-Polanz R, Sperr WR, Mitterbauer G, Födinger M, Schernthaner GH, Christian Bankl H, Gebhart W, Chott A, Lechner K, Valent P.
    Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
    [Abstract] [Full Text] [Related]

  • 6. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
    Florian S, Krauth MT, Simonitsch-Klupp I, Sperr WR, Fritsche-Polanz R, Sonneck K, Födinger M, Agis H, Böhm A, Wimazal F, Horny HP, Valent P.
    Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
    [Abstract] [Full Text] [Related]

  • 7. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M, Żawrocki A, Nedoszytko B, Wasąg B, Niedoszytko M, Jassem E, Nowicki R, Żmijewski MA, Biernat W.
    Int Arch Allergy Immunol; 2014 Mar; 165(2):104-10. PubMed ID: 25402852
    [Abstract] [Full Text] [Related]

  • 8. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I, Jara-Acevedo M, Morgado JM, García-Montero A, Sánchez-Muñoz L, Teodósio C, Matito A, Mayado A, Caldas C, Mollejo M, Orfao A, Escribano L.
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [Abstract] [Full Text] [Related]

  • 9. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2010 Jan; 77(4):169-80. PubMed ID: 20616612
    [Abstract] [Full Text] [Related]

  • 10. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
    Escribano L, Díaz-Agustín B, Bellas C, Navalón R, Nuñez R, Sperr WR, Schernthaner GH, Valent P, Orfao A.
    Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
    [Abstract] [Full Text] [Related]

  • 11. Mastocytosis and related disorders.
    Chiu A, Orazi A.
    Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
    [Abstract] [Full Text] [Related]

  • 12. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).
    Horny HP, Sotlar K, Stellmacher F, Valent P, Grabbe J.
    J Clin Pathol; 2006 Mar; 59(3):264-8. PubMed ID: 16505276
    [Abstract] [Full Text] [Related]

  • 13. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP, Hornick JL.
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [Abstract] [Full Text] [Related]

  • 14. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S, Flaig MJ, Ruëff F, Walz C, Haferlach T, Krokowski M, Kerler R, Petat-Dutter K, Horny HP, Sotlar K.
    Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
    [Abstract] [Full Text] [Related]

  • 15. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
    [Abstract] [Full Text] [Related]

  • 16. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
    Ahn YM, Hong GU, Kim SH, Lee HJ, Baek HS, Kim MN, Park KY, Ro JY.
    Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
    [Abstract] [Full Text] [Related]

  • 17. [Vulvar oedema revealing systemic mastocytosis].
    Deveza E, Locatelli F, Girardin M, Valmary-Degano S, Daguindau E, Aubin F, Humbert P, Pelletier F.
    Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
    [Abstract] [Full Text] [Related]

  • 18. [Systemic mastocytosis].
    Niedoszytko M, Lange M, Chelminska M, Jaśkiewicz K, Piskosz A, Wasag B, Lewandowski K, Mital A, Renke J, Gruchała-Niedoszytko M, Woźniak M, Babińska A, Jassem E.
    Pneumonol Alergol Pol; 2005 Nov; 73(3):239-44. PubMed ID: 16989160
    [Abstract] [Full Text] [Related]

  • 19. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM, Perbellini O, Johnson RC, Teodósio C, Matito A, Álvarez-Twose I, Bonadonna P, Zamò A, Jara-Acevedo M, Mayado A, Garcia-Montero A, Mollejo M, George TI, Zanotti R, Orfao A, Escribano L, Sánchez-Muñoz L.
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [Abstract] [Full Text] [Related]

  • 20. Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?
    Akin C, Scott LM, Metcalfe DD.
    Leuk Res; 2001 Jul; 25(7):635-8. PubMed ID: 11377688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.